Why has my tirzepatide stopped working?

What "Stopped Working" Usually Means

Nine out of ten "tirzepatide stopped working" consults resolve into one of these:

• Normal plateau behavior: 2–6 week stalls are expected even on working doses. Not a plateau until ≥ 6 weeks of flat 4-week averages.
• Caloric creep: eating more than you realize as appetite partially rebounds
• Not at therapeutic dose: plateau at 5 mg or 7.5 mg often resolves with further titration
• Life change: travel, stress, sleep loss, new medication — one of these is almost always the real culprit

The Caloric Creep Curve

Typical tirzepatide trajectory:

• Month 1–3: appetite suppression is overwhelming. Many users eat < 1,500 kcal/day unintentionally.
• Month 4–6: body partially adapts. Appetite returns in smaller windows (late afternoon, evenings). Intake creeps to 1,700–1,900 kcal.
• Month 7–12: further adaptation. Intake often reaches 2,000–2,200 kcal. If that matches your new maintenance TDEE, you plateau.

This isn't the drug losing efficacy — it's the drug's effect size stabilizing while your body's energy expenditure decreases with weight loss, closing the deficit gap.

Step 1: Confirm the Plateau Is Real

• Use weekly average weight
• Compare 4-week rolling means
• Account for cycle, sodium, travel
• Minimum 6 weeks of flat 4-week averages = real plateau

Step 2: 10-Day Food Audit

Track everything — weigh food, log drinks, include bites and tastes. Most plateaued patients discover they're eating 300–700 kcal more than they believed. The fix reveals itself.

Step 3: Dose Review

• If on 2.5 mg: you're on the starting dose. Titrate up.
• If on 5 mg: still below therapeutic for most. Consider escalation.
• If on 7.5 mg: the median effective dose. Most patients benefit from moving to 10–12.5 mg.
• If on 10 mg: titrate to 12.5 or 15 mg if side effects tolerable.
• If on 12.5 mg: 15 mg is the next move.
• If on 15 mg (max): you've exhausted dose lever. Move to protocol audit.

Step 4: Check Life Variables

Any of the following can stall progress by 50–100%:

• Sleep < 6 hr/night for 2+ weeks
• Chronic stress, unresolved
• New medication: steroids, antidepressants, beta blockers, hormonal contraceptives
• Menopausal transition / peri
• New thyroid issue
• Alcohol consumption increase

Step 5: Add Resistance Training

Muscle mass drives BMR. After meaningful weight loss, BMR drops; building back some lean mass via resistance training can add 100–200 kcal/day to energy expenditure — enough to break a plateau. 2–3 sessions/week, compound movements, progressive overload.

Step 6: Increase Protein

1.4–1.8 g/kg/day minimum. Protein has the highest thermic effect of all macronutrients (~25% TEF vs 5% for carbs/fat) and is most satiating. Increasing protein often restarts loss even without changing total calories.

Step 7: Address Sleep Specifically

This deserves its own step because it's underappreciated. Sleep < 6 hours:

• Elevates cortisol and ghrelin
• Reduces leptin
• Reduces NEAT
• Blunts glucose tolerance

Fix sleep and the plateau often fixes itself within 3 weeks.

Step 8: Consider Retatrutide or Combination Therapy

If you've been at 15 mg max dose for 4+ months and you've audited everything above, options for refractory plateau:

• Retatrutide (triple agonist, FDA approval expected 2026): phase 2/3 trials show 22–24% weight loss; stronger effect than tirzepatide
• Metformin 1,500–2,000 mg/day: modest synergy with GLP-1s
• Topiramate 25–100 mg/day: appetite suppressant, off-label but common in obesity medicine
• Bariatric surgery evaluation: for BMI > 35 with comorbidities who've maxed pharmacotherapy

What NOT to Do

• Don't stack tirzepatide with semaglutide — no additional benefit, major side effects
• Don't skip doses to "reset" the drug
• Don't crash diet below 1,200 kcal/day (women) or 1,500 kcal/day (men)
• Don't add stimulants (ephedrine, illicit fat burners)

Accepting the Result

Sometimes the plateau is your biology's floor on this drug. If you've lost 15–20% of body weight and hit a genuine plateau at 15 mg max dose, you are at or above the mean trial result. That's a clinical success. Moving to maintenance (with continued drug) may be the right answer rather than chasing further loss.

See the tirzepatide guide. Related: tirzepatide vs semaglutide, dosage chart.